NANCY P CARAWAY to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications NANCY P CARAWAY has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.172
-
Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations. Cancer. 2005 Feb 25; 105(1):35-43.
Score: 0.071
-
Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res. 2010 Aug 01; 16(15):3976-87.
Score: 0.026
-
Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res. 2007 Aug 15; 67(16):7901-6.
Score: 0.021
-
Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Int J Cancer. 2005 Aug 20; 116(2):285-90.
Score: 0.018
-
Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer. Clin Cancer Res. 2005 Aug 01; 11(15):5417-24.
Score: 0.018
-
Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia. 2004 Sep-Oct; 6(5):623-35.
Score: 0.017